Mukherjee, Debabrata

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal

Acute Myocardial Infarction ResearchCardiac Imaging and Diagnostics

Cited by 8,261

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology

Acute Myocardial Infarction ResearchAntiplatelet Therapy and Cardiovascular Diseases

Cited by 3,595

Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors

Mukherjee, D. (2001) · JAMA

Inflammatory mediators and NSAID effectsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 1,741

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery

Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Circulation

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 1,355

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 1,059

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Circulation

Acute Myocardial Infarction ResearchAntiplatelet Therapy and Cardiovascular Diseases

Cited by 625

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease

Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · The Journal of Thoracic and Cardiovascular Surgery

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 304

A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19

Thakur, B., Dubey, P., Benitez, J., Torres, J. P., Reddy, S., Shokar, N., Aung, K., Mukherjee, D., & Dwivedi, A. K. (2021) · Scientific Reports

COVID-19 Clinical Research StudiesCOVID-19 epidemiological studies

Cited by 284

Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis

CHATTERJEE, S., SARDAR, P., LICHSTEIN, E., MUKHERJEE, D., & AIKAT, S. (2013) · Pacing and Clinical Electrophysiology

Atrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studies

Cited by 113

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome

Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC

Diabetes, Cardiovascular Risks, and LipoproteinsChronic Kidney Disease and Diabetes

Cited by 90

Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective

Dumasia, R., Eagle, K., Kline-Rogers, E., May, N., Cho, L., & Mukherjee, D. (2005) · Current Drug Target -Cardiovascular & Hematological Disorders

Peroxisome Proliferator-Activated ReceptorsDiabetes Treatment and Management

Cited by 56

Device thrombosis with bioresorbable scaffolds

Mukherjee, D. (2017) · New England Journal of Medicine

Coronary Interventions and DiagnosticsAcute Myocardial Infarction Research

Cited by 22

2025 ACC/AHA Clinical Practice Guidelines Core Principles and Development Process

Otto, C. M., Abdullah, A. R., Davis, L. L., Ferrari, V. A., Fremes, S., Mukherjee, D., Prestera, L., & Ziaeian, B. (2026) · JACC

Clinical practice guidelines implementationHealth Sciences Research and Education

Cited by 7

Guidance for Incorporating FDA Processes Into the ACC/AHA Clinical Practice Guideline Methodology

Jneid, H., Abdullah, A. R., Ferrari, V. A., Kovacs, R. J., Mukherjee, D., & Shimbo, D. (2026) · JACC

Clinical practice guidelines implementationHealthcare Regulation

Cited by 4